
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -2.38095238095 | 1.68 | 1.7 | 1.6 | 120622 | 1.64831023 | CS |
4 | -0.06 | -3.52941176471 | 1.7 | 1.83 | 1.57 | 239623 | 1.68912121 | CS |
12 | -0.01 | -0.606060606061 | 1.65 | 1.95 | 1.57 | 290932 | 1.73430513 | CS |
26 | -4.13 | -71.5771230503 | 5.77 | 7.88 | 1.4 | 582062 | 1.69201709 | CS |
52 | -7.6 | -82.2510822511 | 9.24 | 9.6 | 1.4 | 316901 | 2.1024533 | CS |
156 | -5.73 | -77.7476255088 | 7.37 | 11.67 | 1.4 | 497582 | 3.94780516 | CS |
260 | -2.69 | -62.1247113164 | 4.33 | 36 | 1.4 | 390850 | 6.79913495 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales